Found 3 articles for: "Rituximab"
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
April 2025 | Volume 24 | Issue 4 | Original Article | 387 | Copyright © April 2025
Read MoreJuvenile Pemphigus Foliaceus in a Patient With Psoriasis Receiving Narrow-Band Ultraviolet-B: Successful Treatment With Rituximab
August 2023 | Volume 22 | Issue 8 | Case Reports | 830 | Copyright © August 2023
Pemphigus foliaceus is an autoimmune blistering disease of the skin that is not frequently associated with mucous membrane involvement. It is characterized by immunoglobulin G (IgG) antibodies ag...
Read MoreRituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
August 2022 | Volume 21 | Issue 8 | Case Reports | 894 | Copyright © August 2022
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the sc...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.